Abiopharma

Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

Avient To Hold Fourth Quarter 2025 Conference Call

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026

Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC

Merck to Complete Acquisition of Cidara Therapeutics

Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3